Stay updated on MEDI 4736 Combo in Head/Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI 4736 Combo in Head/Neck Cancer Clinical Trial page.

Latest updates to the MEDI 4736 Combo in Head/Neck Cancer Clinical Trial page
- Check4 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed; no other core content or data changes.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated to include information on head and neck squamous cell carcinoma, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.4%
- Check18 days agoChange DetectedThe webpage has undergone significant updates, including the addition of detailed drug information for multiple compounds and the inclusion of numerous new locations across various countries. Additionally, the facility name and the Genetic and Rare Diseases Information Center have been added.SummaryDifference15%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to include detailed information about a Phase III clinical trial for MEDI4736 in treating recurrent/metastatic head and neck cancer, including study design, eligibility criteria, and locations of research sites across multiple countries.SummaryDifference100%
Stay in the know with updates to MEDI 4736 Combo in Head/Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI 4736 Combo in Head/Neck Cancer Clinical Trial page.